6505-01-283-3658 ( NDC00641-2766-41 , 16130 , NDC00469-1610-50 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-283-3658 | 6505 | 012833658 | SULFAMETHOXAZOLE AND TRIMETHOPRI | 6654 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| FEAT | SPECIAL FEATURES | STERILE SOLUTIONS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 80.000 MILLIGRAMS SULFAMETHOXAZOLE ACTIVE INGREDIENT AND 16.000 MILLIGRAMS TRIMETHOPRIM ACTIVE INGREDIENT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 30.000 MILLILITERS |
| CQCT | PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |
| CSGS | ADMINISTRATION | INTRAVENOUS |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00641-2766-41 | 51968 | A | 2 | 3 | 4 | 54 | |
| 16130 | 39832 | A | 2 | 3 | 6 | 54 | |
| NDC00469-1610-50 | 39832 | A | 2 | 3 | 6 | 54 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00641-2766-41 | 51968 | ELKINS-SINN INC | A | A |
| 16130 | 39832 | ASTELLAS PHARMA US INC. | F | A |
| NDC00469-1610-50 | 39832 | ASTELLAS PHARMA US INC. | F | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| U | X | A | 1 | 08/03/1 | P | 3004909105 | 6654 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V | K | U/I CONTAINS 30 ML |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | U | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | 0 | VI | M | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|